Diagnosed with Kidney Cancer After Military Service?
REE Medical works with physicians experienced in urologic oncology VA claims. They can document your diagnosis, treatment history, and residual kidney function to support the maximum rating — including the crucial six-month post-treatment review and secondary conditions like hypertension and chronic kidney disease.
Learn About REE Medical's Cancer Claim Support →claim.vet may receive a referral fee if you use this link. Veterans never pay more.
The PACT Act (Sergeant First Class Heath Robinson Honoring our Promise to Address Comprehensive Toxics Act of 2022) created a legal presumption of service connection for kidney cancer in veterans with qualifying toxic exposure service. Before the PACT Act, veterans with kidney cancer had to prove their specific cancer was caused by their specific military service — an evidentiary task that was nearly impossible because individual cancer causation cannot be definitively proven.
The PACT Act recognized this fundamental problem and resolved it by shifting the burden: veterans with a qualifying service history and a covered cancer diagnosis are now entitled to service connection by presumption. VA must accept the claim unless it has clear and unmistakable evidence to the contrary — a standard that virtually never exists in individual cancer cases.
Kidney cancer (renal cell carcinoma and other malignant neoplasms of the kidney) is among the PACT Act's covered cancers because of the well-documented association between occupational exposure to chemical carcinogens — particularly trichloroethylene, benzene, cadmium, and polycyclic aromatic hydrocarbons — and elevated kidney cancer rates. All of these compounds are found in burn pit smoke, contaminated groundwater on military installations, jet fuel, and other hazardous materials commonly encountered in military service environments.
To receive PACT Act presumptive service connection for kidney cancer, a veteran must meet the following service criteria:
| Service Location | Qualifying Period |
|---|---|
| Southwest Asia theater (Iraq, Kuwait, Saudi Arabia, Bahrain, Qatar, UAE, Oman) | On or after August 2, 1990 |
| Afghanistan, Uzbekistan, Syria, or Djibouti | On or after September 11, 2001 |
| Somalia or Djibouti | On or after August 2, 1990 |
| Egypt, Jordan, Lebanon, or Yemen | As specified in VA regulations |
Active duty, National Guard, and Reserve members who were federally activated and deployed to qualifying locations are all eligible. The type of unit, military occupational specialty, and proximity to actual burn pits is not legally required — qualifying service in the area during the covered period is sufficient.
While not legally required for PACT Act presumptive claims, registering in the VA Airborne Hazards and Open Burn Pit Registry is strongly recommended before filing. Registration creates an official documented record of your exposure acknowledgment and may support your claim if any questions arise about your service history. Registration is free and available at VA.gov.
VA rates kidney cancer under Diagnostic Code 7528 — malignant neoplasms of the genitourinary system. This DC covers the full spectrum of kidney malignancies, including:
The rating structure under DC 7528 has two phases: active cancer and post-treatment residuals.
| Phase | Rating | Duration |
|---|---|---|
| Active malignant neoplasm (under treatment) | 100% | Throughout active treatment |
| Post-treatment minimum period | 100% | 6 months after treatment completion (38 CFR § 4.29) |
| Residuals (after 6-month period) | Based on function | Ongoing, rated under applicable kidney/renal DC codes |
Any service-connected active cancer is rated at 100% by VA regulation. Under 38 CFR § 4.29, a malignant neoplasm that is actively present — whether under chemotherapy, immunotherapy, targeted therapy, radiation, surgical treatment, or a combination — must be rated at 100%.
This 100% rating is mandatory, not discretionary. If VA has service-connected your kidney cancer and it is active, you are entitled to 100% compensation regardless of your functional limitations in daily life. Many veterans don't realize this and accept lower ratings during treatment — this is an error that should be challenged.
The 100% during active treatment also means:
After active treatment ends — whether surgery, chemotherapy completion, radiation completion, or a combination — your 100% rating is maintained by regulation for at least six months. This is the "six-month rule" under 38 CFR § 4.29.
The six-month rule serves two purposes: it acknowledges that cancer recovery takes time and that the risk of recurrence is highest immediately after treatment; and it ensures veterans have time to be properly evaluated for residual conditions before any rating reduction occurs.
After the six-month period, VA is required to conduct a re-examination (C&P exam) to evaluate:
The six-month post-treatment window is when you should be building your residuals documentation — not waiting for VA to ask. Get current kidney function labs, updated blood pressure records, audiology testing if applicable, and physician notes documenting all functional limitations. Coming to your review exam with thorough documentation of every residual significantly improves your post-treatment rating.
Partial or total nephrectomy is the primary surgical treatment for kidney cancer. The post-nephrectomy rating under DC 7528 and related codes depends on the extent of kidney function loss:
| Residual Condition | DC Code | Rating Basis |
|---|---|---|
| Nephrectomy (kidney removed, function preserved in remaining kidney) | DC 7529 | At least 30% rating for loss of one kidney |
| Renal insufficiency (reduced function, eGFR 30-59) | DC 7541 | 30% or higher based on function level |
| Severe renal insufficiency (eGFR < 30) | DC 7541 | 60-100% based on severity |
| Dialysis dependence | DC 7541 | 100% |
| Hypertension secondary to kidney damage | DC 7101 | 10-60% based on BP measurements |
A veteran with a total nephrectomy but normal function in the remaining kidney receives at minimum a 30% rating under DC 7529. This rating reflects the functional and medical significance of living with a single kidney — increased vulnerability to further kidney injury, dietary restrictions, medication monitoring requirements, and the serious consequences of any future kidney insult.
Kidney cancer is commonly treated with immunotherapy (nivolumab, pembrolizumab, ipilimumab) and targeted therapies (sunitinib, pazopanib, cabozantinib). These modern treatments cause distinctive residuals:
Secondary service connection claims can significantly increase your total combined VA disability rating. For kidney cancer veterans, the most common and high-value secondary claims are:
The kidney is the primary regulator of blood pressure through the renin-angiotensin-aldosterone system. Removal of or damage to one kidney disrupts this regulatory system. Veterans who develop hypertension after nephrectomy or kidney damage from cancer treatment have strong secondary connection claims. Hypertension is rated 10-60% based on diastolic pressure measurements and required medications.
Progressive kidney function decline following nephrectomy or nephrotoxic chemotherapy (cisplatin, for example) can produce chronic kidney disease. As eGFR declines over years, this condition becomes independently ratable and can be service-connected as secondary to the kidney cancer treatment.
Depression, anxiety, and PTSD secondary to cancer diagnosis and its life-altering consequences are legitimate secondary claims. Cancer-related psychological distress is well-documented and increasingly recognized in VA adjudication. These conditions are rated under DC 9400 (depression), DC 9413 (anxiety), or DC 9411 (PTSD) based on symptom severity.
Cisplatin, used in some kidney cancer treatment regimens, is ototoxic — it permanently damages hearing. Veterans who received cisplatin and have subsequent sensorineural hearing loss have a clear secondary service connection claim. Audiometric testing documents the degree of hearing loss for rating under DC 6100.
Connect with a VA-Accredited Attorney
Kidney cancer claims with multiple residuals, secondary conditions, and potential SMC issues benefit significantly from legal representation. VA-accredited attorneys work on contingency — no fee unless you win back pay.
Find a VA-Accredited Attorney →For your initial C&P exam during active treatment, bring all medical records and focus on confirming the cancer is active and service-connected. The exam is relatively straightforward when cancer is active — the 100% rating follows automatically.
The six-month post-treatment review exam is more consequential. Preparation is critical:
Kidney cancer after burn pit exposure may qualify you for 100% VA disability. See where you stand — free, no phone calls.
Check My Eligibility — Free →Editorial Standards: Written by Marcus J. Webb, veterans benefits researcher. Verified against current 38 CFR regulations and PACT Act provisions. Last reviewed: July 2026. Not legal advice — for representation, connect with a VA-accredited attorney.